Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Eris Lifesciences Ltd.
NSE: ERIS
|
BSE: 540596
|
ISIN: INE406M01024
|
Industry: Pharmaceuticals
Results
|
Turnaround Potential
1769.1000
-39.30
(
-2.17
%)
NSE
Aug 04, 2025
11:03 AM
68.32% Gain from 52W Low
Volume:
33,663
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Eris Lifesciences Ltd.
05 Feb 2025
Results
1769.10
-2.17%
Eris Lifesciences (BUY): First player to launch GLP products in India
Buy:
Eris Lifesciences Ltd.
by
BOB Capital Markets Ltd.
Target: 1418 | Target met
Target
BOB Capital Markets Ltd.
Base domestic growth at 12% vs IMP growth of 8% due to new product launches and price increase
Number of FII/FPI investors increased from 178 to 193 in Jun 2025 qtr.
More from Eris Lifesciences Ltd.
Recommended
Market trades higher, MCX's Q1 net profit surges 83.2% YoY to Rs 203.1 crore
Trendlyne Marketwatch |
04 Aug 2025, 10:47AM
Five Interesting Stocks Today - August 1, 2025
The Baseline |
01 Aug 2025
Earnings Call Transcript - Q1FY21 for Eris Lifesciences
|
04 Aug 2020